Founded in 2015, Montreal-based Inversago Pharma is a leader in the development of next-generation CB1 receptor blocker therapies designed to treat obesity, diabetes, and the complications associated with an array of metabolic disorders.
We are the venture capital agency of the government of Ontario
Venture Ontario is the venture capital investment agency of the government of Ontario. Venture Ontario was created to promote and develop the venture capital sector in Ontario, to assist high potential technology companies access capital vital to grow and prosper.
Venture Ontario News
The latest news from Venture Ontario
June 5, 2024
Ontario Investing $40 Million in Life Sciences Sector
The Ontario government is investing $40 million from the Venture Ontario Fund, dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets. This new funding will help the province’s researchers and companies develop innovative life-saving medicines and technologies of tomorrow.
June 5, 2024
McRock Launches New Fund to Invest in AI-Enabled Industrial Software Companies
The future of digital transformation just got brighter for industrial sectors, as McRock Capital launches Fund III with an initial close of US $81 million.
